What is GIP-36?

GIP-36 is a cutting-edge peptide discovered by Dr. Gerald Mizejewski, designed to regulate immune response and promote cellular health. This revolutionary peptide has shown promise in diffusing the autoimmune response and fostering balance in the body’s systems.

How It Works:

• Targets and regulates overactive immune responses.
• Helps cells communicate effectively for better function.
• Encourages cellular repair and renewal for long-term health benefits.

Scientific Background:

The mechanism of GIP-36 is rooted in its role as a cell regulator that modulates the immune response. Specifically, GIP-36 acts on immune pathways involved in inflammation and autoimmune reactions. Here’s a breakdown of its mechanism:

Regulation of Cytokine Activity:

GIP-36 influences the activity of pro-inflammatory cytokines, reducing their levels to dampen excessive immune responses. This helps control the overactivation of immune cells often seen in autoimmune diseases.

T-cell Modulation:

The peptide can modulate the behavior of T-cells, particularly by promoting regulatory T-cells (Tregs), which are essential for maintaining immune tolerance and preventing the immune system from attacking the body’s tissues.

Cellular Repair and Maintenance:

By interacting with cellular signaling pathways, GIP-36 aids in repairing and maintaining the integrity of tissues affected by autoimmune damage. This may involve promoting anti-apoptotic and pro-survival signals in targeted cells.

Neuroendocrine-Immune Axis:

GIP-36 may also interact with the neuroendocrine-immune axis, indirectly affecting systemic inflammation and cellular responses.